Medical Research
(H30)
IRS Verified
DX Registered
990 on File
CANCER RESEARCH COLLABORATION INC
Financial strength (30%)
56/100
Reliability (20%)
50/100
Effectiveness (25%)
48/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
. It is the CRC’s mission to facilitate and foster innovation and ground-breaking strategies by working with partners who are similarly committed to finding new and better ways to prevent, diagnose and treat cancer. Each year, our organization assists with clinical research trials to aid in the quest for a cure to cancer.
Financial Overview — FY 2025
$173K
Total Revenue
$7K
Total Expenses
$1.3M
Net Assets
1
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
0.0%
Fundraising Efficiency
0.0%
Operating Reserve
2232.05x
Liability-to-Asset
0.0%
Revenue Diversification
100.0%
Compared with Peers
FY 2025
Compared with 439 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
0.0% | 76.9% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
100.0% | 12.6% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 28.9% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
2232.1 mo | 40.3 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 100.0% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-5.7% | 2.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
13.3% | -2.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
96.1% | 18.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $173K | $7K | $1.3M | 0.0% | 1 |
| 2024 | $183K | $6K | $1.1M | 0.0% | 0 |
| 2023 | $151K | $303K | $917K | 99.2% | 0 |
| 2022 | $213K | $239K | $1.0M | 83.9% | 0 |
| 2021 | $11K | $109K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.